Triangle drugmaker lands $36M deal with Ireland-based pharma
On the eve of a Triangle drugmakers approval for its lead candidate, it has struck a deal with a major pharmaceutical company for $36 million and rights to a new drug -- selling of…
On the eve of a Triangle drugmakers approval for its lead candidate, it has struck a deal with a major pharmaceutical company for $36 million and rights to a new drug -- selling of…